Company: EVLVW
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001628280-25-026845
Chunk: 172

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 1
Chunk 172
---
689)$(11,272)Weighted average common shares outstanding – basic and diluted160,808,391 153,076,719 Net loss per share - basic and diluted$(0.01)$(0.07)Net loss$(1,689)$(11,272)Other comprehensive (loss) incomeCumulative translation adjustment(46)3 Total other comprehensive (loss) income(46)3 Total comprehensive loss$(1,735)$(11,269)

*Includes related party revenue of $1.9 million for the three months ended March 31, 2024. There was no related party revenue for three months ended March 31, 2025.

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-2

Table of Contents

EVOLV TECHNOLOGIES HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In thousands, except share amounts)

(Unaudited)

Common StockAdditionalPaid-inCapitalAccumulated Other Comprehensive Income (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances at December 31, 2024159,602,069 $16 $472,331 $(32)$(354,664)$117,651 Issuance of common stock upon net exercise of stock options281,709 — 20 — — 20 Issuance of common stock upon vesting of restricted stock units3,389,364 — — — — — Stock-based compensation cost— — 5,125 — — 5,125 Cumulative translation adjustment— — — (46)— (46)Net loss— — — — (1,689)(1,689)Balances at March 31, 2025163,273,142 $16 $477,476 $(78)$(356,353)$121,061 Balances at December 31, 2023 (as restated)151,310,080 $15 $444,825 $(53)$(300,647)$144,140 Issuance of common stock upon net exercise of stock options519,089 1 301 — — 302 Issuance of common stock upon vesting of restricted stock units3,527,778 — — — — — Stock-based